Vickie L Capps is Director of Silverback Therapeutics, Inc.. Currently has a direct ownership of 61,576 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Dec 08, 2020, when has been sold 9,523 shares (Common Stock) at a price of $21.0 per share, resulting in proceeds of $199,983. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.6K
0% 3M change
0% 12M change
Total Value Held $0

VICKIE L CAPPS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2020
BUY
Open market or private purchase
$199,983 $21.0 p/Share
9,523 Added 13.39%
61,576 Common Stock

Also insider at

NUVA
NUVASIVE INC Healthcare
AMED
AMEDISYS INC Healthcare
OTIC
OTONOMY, INC. Healthcare
JANX
Janux Therapeutics, Inc. Healthcare
VLC

Vickie L Capps

Director
Baton Rouge, LA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX